Skip to main content

Table 2 PD-L1 expression in mixed UC/SCC and pure SCC

From: Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

  pure SCC mixed UC/SCC
Scores 28–8 22C3 SP 263 SP142 28–8 22C3 SP 263 SP142
TC (%) 0 45 51 33 63 26 39 21 43
TC (%) 1 5 2 10 0 9 2 3 0
TC (%) 2 2 2 4 0 2 1 1 0
TC (%) 3 5 4 5 0 4 1 10 0
TC (%) 4 3 2 6 0 0 0 6 0
TC (%) 5 3 0 5 0 2 1 2 0
IC (%) 0 38 42 24 58 22 35 18 40
IC (%) 1 8 8 21 4 12 2 11 3
IC (%) 2 14 4 14 0 5 6 12 1
IC (%) 3 3 7 4 1 4 1 2 1
CPS < 1 18 39 11 49 13 33 8 36
CPS 1–9 32 10 32 13 20 8 15 5
CPS ≥ 10 13 12 20 1 10 3 20 1
  1. TC tumour cell area (%), IC immune cell area (%), CPS combined positivity score